Surgery for Drug-Resistant Epilepsy in Children
NEJM 377:1639-1647, Dwivedi, R.,et al, 2017
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy
JAMA 313:285-293, Jobst, B.C. & Cascino, G.D., 2015
Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930, Engel, J.,et al, 2012
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
Vagus Nerve Stimulation Therapy for Epilepsy in Older Adults
Neurol 54:1179-1182, Sirven,J.I.,et al, 2000
Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999
Outcome Research in Neurology:Incorporating Health-Related Quality of Life
Ann Neurol 37:141-142, Devinsky,O., 1995
Outcome Assessment for Epilepsy Surgery:The Impact of Measuring Health-Related Quality of Life
Ann Neurol 37:158-166, 1411995., Vickrey,B.G.,et al, 1995
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Outcomes in 248 patients who had Diagnostic Evaluations for Epilepsy Surgery
Lancet 346:1445-1449, Vickrey,B.G.,et al, 1995
The Role of Epilepsy Centers in Delivering Care to Patients with Intractable Epilepsy
Neurol 44:1347-1352, Lesser,R.P., 1994
Medical Assessment and Treatment of Chronic Epilepsy
BMJ 302:363-366, Shorvon,S.D., 1991
Surgery for Epilepsy
National Institutes of Health Concensus Conference, JAMA 264:729-7331990., , 1990
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Brain Tumors in Children
NEJM 386:1922-1931, Cohen, A.R., 2022
Spina Bifida
NEJM 387:444-450, Iskandar, B.J. & Finnell, R.H., 2022
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013
Tourettes Syndrome
BMJ 347:f4964, Cavanna, A.E. & Seri, S., 2013
Incidence and Prevalence of Epilepsy Among Older US Medicare Beneficiaries
Neurol 78:448-453, Faught,E.,et al, 2012
Substitution Monotherapy with Levetiracetam vs Older Antiepileptic Drugs
Arch Neurol 69:1563-1571, Hakami, T.,et al, 2012
Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy: A Decision Analysis
JAMA 300:2497-2505,2548, Choi,H.,et al, 2008
What Constitutes High Quality of Care for Adults With Epilepsy?
Neurol 69:2020-2027, Pugh,M.J.V.,et al, 2007
Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007
Factors Associated With Poor Compliance of Patients with Epilepsy Driving Restrictions
Neurol 67:869-871, Polychronopoulos,P.,et al, 2006
High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Arch Neurol 63:1388-1393, Gladstone,D.E.,et al, 2006
International Subarachnoid Aneurysm Trial (ISAT) of Neurosurgical Clipping Versus Endovascular Coiling in 2143 Patients with Ruptured Intracranial Aneurysms:A Randomised Comparison of Effects on Survival, Dependency, Seizures, Rebleeding, Subgroups, and Aneurysm Occlusion
Lancet 366:809-817,783, Molyneux,A.J.,et al, 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Epilepsy in Low-Grade Gliomas: The Impact on Cognitive Funciton and Quality of Life
Ann Neurol 54:514-520, Klein,M.,et al, 2003
Disability and Quality of Life in Charcot-Marie-Tooth Disease Type 1
JNNP 70:548-550, Pfeiffer,G.,et al, 2001
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Eiplepsy
NEJM 345:311-318,365, Wiebe,S.,et al, 2001
Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000
What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000
Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999
Seizure Frequency and the Health-Related Quality of Life of Adults with epilepsy
Neurol 53:162-166, Leidy,N.K.,et al, 1999
When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999
Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Six-Month Evaluation of Carbatrol (Extended-Release Carbamazepine) in Complex Partial Seizures
Neurol 519:1727-1729, Mirza,W.U.,et al, 1998
Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997